Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KOS-862 in metastatic prostate cancer
NCT00104130Phase 2Terminated
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Epothilone D in prostate cancer (PCa), sponsored by Bristol Myers Squibb. Started Dec 2004; status: terminated.
02
Drugs
Epothilone D
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00104130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00104130.